Use of estradiol-progestin therapy associates with increased risk for uterine sarcomas

Gynecologic Oncology

Volumn 122, Issue 2, 2011, Pages 260-263

  Jaakkola, Susanna ^a   Lyytinen, Heli K ^a   Pukkala, Eero ^b   Ylikorkala, Olavi ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b FINNISH CANCER REGISTRY   (Finland)

Author keywords

Estrogen; Hormone therapy; Leiomyosarcoma; Progestin; Stromal sarcoma; Uterine sarcoma

Indexed keywords

ESTRADIOL; GESTAGEN;

ADULT; ARTICLE; CANCER RISK; CONTROLLED STUDY; ENDOMETRIUM SARCOMA; FEMALE; HORMONAL THERAPY; HUMAN; LEIOMYOSARCOMA; MAJOR CLINICAL STUDY; POSTMENOPAUSE; PRIORITY JOURNAL; RISK ASSESSMENT; UTERUS SARCOMA;

AGED; COHORT STUDIES; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; LEIOMYOSARCOMA; MIDDLE AGED; PROGESTINS; RISK; SARCOMA; TIME FACTORS; UTERINE NEOPLASMS;

EID: 79960448223     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2011.04.003     Document Type: Article

References (26)

1. The North American Menopause Society Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society Menopause 17 2010 242 255
2. R.J. Santen, D.C. Allred, and S.P. Ardoin Postmenopausal therapy: An Endocrine Society scientific statement J Clin Endocrinol Metab 95 2010 1 66
3. J.A. Collins, J.M. Blake, and P.G. Crosignani Breast cancer risk with postmenopausal hormone treatment Hum Reprod Update 111 2005 545 560 (Pubitemid 41631306)
4. C.L. Pearce, K. Chung, M.C. Pike, and A.H. Wu Increased ovarian cancer risk associated with menopausal estrogen therapy is reduced by adding a progestin Cancer 115 2009 531 539
5. H.L. Judd, I. Mebane-Sims, and C. Legault Effects of hormone replacement therapy on endometrial histology in postmenopausal women. The postmenopausal estrogen/progestin interventions JAMA 275 1996 370 375
6. V. Beral, D. Bull, and G. Reeves Million women study. Endometrial cancer and hormone-replacement therapy in the million women study Lancet 365 2005 1543 1551
7. J.A. Doherty, K.L. Cushing-Haugen, B.S. Saltzman, L.F. Voigt, D.A. Hill, and S.A. Beresford Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer Am J Obstet Gynecol 197 139 2007 e1 e7
8. S. Jaakkola, H. Lyytinen, E. Pukkala, and O. Ylikorkala Nationwide study on endometrial cancer in postmenopausal women using estradiol-progestin therapy Obstet Gynecol 114 2009 1197 1204
9. The Finnish Cancer Registry Available at: http://www.cancerregistry.fi
10. E. D'Angelo, and J. Prat Uterine sarcomas: A review Gynecol Oncol 116 2010 131 139
11. S.M. Schwartz, N.S. Weiss, and J.R. Daling Exogenous sex hormone use, correlates of endogenous hormone levels, and the incidence of histologic types of sarcoma of the uterus Cancer 1995 717 724 (Pubitemid 26055397)
12. A. Gadducci, S. Cosio, A. Romanini, and A.R. Genazzani The management of patients with uterine sarcoma: A debated clinical challenge Crit Rev Oncol Hematol 65 2008 129 142
13. O. Reich, S. Regauer, W. Urdl, M. Lahousen, and R. Winter Expression of estrogen and progesterone receptors in low-grade endometrial stromal sarcomas Brit J Cancer 82 2000 1030 1034 (Pubitemid 30128855)
14. H. Lyytinen, E. Pukkala, and O. Ylikorkala Breast cancer risk in postmenopausal women using estradiol-progestogen therapy Obstet Gynecol 113 2009 65 73
15. L. Teppo, E. Pukkala, and M. Lehtonen Data quality and quality control of a population-based cancer registry. Experience in Finland Acta Oncol 33 1994 365 369 (Pubitemid 24207996)
16. I. Keskimaki, S. Aro, and J. Teperi Regional variation in surgical procedure rates in Finland Scand J Soc Med 22 1994 132 138 (Pubitemid 24191574)
17. International classification of diseases for oncology. Third Edition. 2000. World Health Organization. Geneva.
18. D.G. Mutch, J. Gall, and I. Gall The new FIGO staging system for cancers of vulva, cervix, endometrium and sarcomas Gynecol Oncol 115 2009 325 328
19. K.J. Rothman, and S. Greenland Modern epidemiology 2nd edition 1998 Lippincott-Raven Publishers Philadelphia (PA)
20. R. Luoto, J. Raitanen, E. Pukkala, and A. Anttila Effect of hysterectomy on incidence trends of endometrial and cervical cancer in Finland 1953-2010 Br J Cancer 90 2004 1756 1759 (Pubitemid 38725647)
21. A.T. Omera Uterine sarcomas: Have we made any progress? Curr Opin Obstet Gynecol 16 2004 1 4
22. D.L. Wickerham, B. Fisher, and N. Wolmark Association of tamoxifen and uterine sarcoma J Clin Oncol 20 2002 2758 2760
23. P. Topo, R. Luoto, E. Hemminki, and A. Uutela Declining socioeconomic differences in the use of menopausal and postmenopausal hormone therapy in Finland Maturitas 32 1999 141 145 (Pubitemid 29389728)
24. M.M. Leitao, R.A. Soslow, and D. Nonaka Tissue microarray immunohistochemical expression of estrogen, progesterone, and androgen receptors in uterine leiomyomata and leiomyosarcoma Cancer 101 2004 1455 1462 (Pubitemid 39180402)
25. M.C. Chu, G. Mor, C. Lim, W. Zheng, V. Parkash, and P.E. Schwartz Low-grade endometrial stromal sarcoma: Hormonal aspects Gynecol Oncol 90 2003 170 176 (Pubitemid 37338093)
26. D. Pink, T. Lindner, and A. Mrozek Harm or benefit of hormonal treatment in metastatic low-grade endometrial stromal sarcoma: Single center experience with 10 cases and review of the literature Gynecol Oncol 101 2006 464 469 (Pubitemid 44251067)